KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments

Posted on Mar 02, 2021, 3 p.m.


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.


The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta-lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.  


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta-lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://www.worldhealth.net/news/antibiotic-tolerance-study-paves-way-new-treatments/


List of Articles
번호 제목 글쓴이 날짜 조회 수
359 [정원석 교수님] 제28회 삼성휴먼테크 논문대상에서 생명과학과 변유경 학생 은상 수상​ 생명과학과 2022.03.02 772
358 [조병관 교수님] 한국연구재단, 노화 방지하고 회춘하는 방법 제시 생명과학과 2022.01.13 775
357 [조원기 교수님] 세포 기능 결정에 핵심 역할 유전자 발현 단백질 찾았다 생명과학과 2021.12.24 782
356 손종우 교수님_비정형 항정신병 약물에 의한 비만의 원인 규명​ 생명과학과 2021.05.17 788
355 [김찬혁 교수님] 카이스트, 면역관문 신호 극복하는 차세대 CAR-T 세포 치료제 개발 생명과학과 2021.11.24 792
354 [김상규 교수님] 식물 유전자 비밀 푸는 김상규 카이스트 교수 생명과학과 2021.11.24 799
353 [정현정 교수님] 유전자 가위로 생체 내 정밀한 유전자 교정에 의한 면역 항암 치료​ 생명과학과 2022.01.18 810
352 서성배 교수님_Gut hormone triggers craving for more proteins 생명과학과 2021.05.18 813
351 [김상규 교수님] 구글도 올라 탄 神으로 가는 길[과학을읽다] 생명과학과 2022.09.07 844
350 전상용, 송지준 교수님_다양한 변이에도 면역 가능한 인플루엔자 백신 개발 생명과학과 2021.06.30 849
349 서성배 교수님_동물 뇌 신경세포가 과식 억제한다 생명과학과 2021.06.16 860
348 한진희 교수님_기억이 만들어지는 원리 최초로 규명했다 생명과학과 2021.07.14 866
347 [김상규 교수님] 꽃향기, 이젠 눈으로 보세요!​ 생명과학과 2022.05.10 867
346 [김학성 교수님] 카이스트, 거대 단백질 구조체를 레고 블록 쌓듯 조립하는 기술 개발 생명과학과 2021.11.24 877
345 김대수 교수님_“뇌의 본능적 욕구 참고 기다리는 아이, 사회적으로 성공” 생명과학과 2021.09.06 890
344 허원도 교수님(유다슬이 박사)_제10회 에쓰-오일 우수학위논문상'의 생명과학 분야 대상 수상 생명과학과 2021.02.22 901
343 김진우 교수님, 천주교 서울대교구 생명위원회 제 15회 '생명의 신비상' 수상 생명과학과 2021.02.18 905
342 [김세윤, 이대엽 교수님] "후성유전 조절하는 핵심 분자기전 찾았다" 생명과학과 2022.06.02 928
341 [정현정 교수님] 유전자 가위와 약물로 동시에 암을 잡는 신약 개발 생명과학과 2023.08.03 959
» 조병관 교수님_Antibiotic tolerance study paves way for new treatments 생명과학과 2021.03.03 969
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 22 Next
/ 22